Position in HROW
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
10 quarters on record
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Derivatives in HROW
reported options exposure · as of Mar 31, 2026CallValue
$634,680
CallShares
18,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $613,305,594 across 42 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
99,106 | $58,767,875 | |
| 2 | VTRS |
Viatris Inc
|
3,882,541 | $52,453,128 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,602,543 | $48,199,096 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
959,257 | $46,188,223 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
7,788,811 | $45,175,103 | |
| 6 | PCRX |
Pacira BioSciences, Inc.
|
1,982,724 | $44,809,561 | |
| 7 | LQDA |
Liquidia Corp
|
873,065 | $32,949,472 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
622,450 | $32,174,439 |
All Filings in HROW
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $634,680 | 18,000 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $882,000 | 18,000 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $264,845 | 5,497 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,357,908 | 208,183 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $12,453,800 | 468,188 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $22,301,154 | 664,714 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $28,001,897 | 622,818 | Shares | Defined | 2024-11-14 | |
| 2023-03-31 | $866,078 | 40,930 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,601,843 | 108,526 | Shares | Defined | 2023-02-14 | |
| 2021-06-30 | $334,950 | 36,055 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||